{"id":72055,"date":"2025-09-18T20:51:24","date_gmt":"2025-09-19T00:51:24","guid":{"rendered":"https:\/\/bgodinspired.com\/index.php\/bgodinspired-news\/bgodinspired-health-news\/wegovy-pill-could-deliver-as-much-weight-loss-as-the-shot-trial-shows\/"},"modified":"2025-09-18T20:51:24","modified_gmt":"2025-09-19T00:51:24","slug":"wegovy-pill-could-deliver-as-much-weight-loss-as-the-shot-trial-shows","status":"publish","type":"post","link":"https:\/\/bgodinspired.com\/index.php\/bgodinspired-news\/bgodinspired-health-news\/wegovy-pill-could-deliver-as-much-weight-loss-as-the-shot-trial-shows\/","title":{"rendered":"Wegovy pill could deliver as much weight loss as the shot, trial shows"},"content":{"rendered":"
\n
\n \t<\/i> Read Time:<\/span>2 Minute, 43 Second <\/div>\n\n <\/div>

<\/p>\n

The Race for Weight-Loss Supremacy: Eli Lilly vs. Novo Nordisk<\/strong><\/p>\n

In a rapidly evolving weight-loss market, pharmaceutical giants Eli Lilly and Novo Nordisk are racing to bring obesity pills to the forefront. Both companies, having successfully launched their injectable weight-loss medications, are making significant strides towards oral alternatives that could transform treatment for millions battling obesity.<\/p>\n

Approval on the Horizon<\/strong><\/p>\n

Earlier this year, Novo Nordisk submitted its oral obesity pill for review by the United States Food and Drug Administration (FDA), anticipating a decision by year’s end. Eli Lilly, on the other hand, has announced plans to seek approval for orforglipron later this year. Initial results from its clinical trials show promising outcomes, suggesting that this new pill could lead to superior blood sugar and weight reductions compared to existing treatments.<\/p>\n

Novo Nordisk’s clinical trials indicate an average weight loss of 13.6% among participants taking their oral semaglutide pill, compared to just 2.2% among those on a placebo. Notably, about a third of participants experienced a weight loss of 20% or more, along with improvements in physical activity and cardiovascular health.<\/p>\n

Side Effects and Consumer Choices<\/strong><\/p>\n

While the efficacy of these medications is noteworthy, side effects remain a significant concern. Novo Nordisk reported that nearly half of its trial participants experienced nausea, and about 7% withdrew from the study due to adverse reactions. Eli Lilly’s trials saw a somewhat similar trend, with 10% of participants mengalami side effects severe enough to drop out.<\/p>\n

Interestingly, experts are weighing the potential convenience offered by orforglipron, which can be taken without food restrictions, against the potency of Novo Nordisk’s oral semaglutide.<\/p>\n

A Larger Conversation on Wellness<\/strong><\/p>\n

This competition in the pharmaceutical sector raises broader questions about our approaches to health and well-being\u2014a topic echoed throughout Scripture. In 1 Corinthians 6:19-20, we are reminded, \u201cDo you not know that your bodies are temples of the Holy Spirit, who is in you, whom you have received from God? You are not your own; you were bought at a price. Therefore honor God with your bodies.\u201d<\/p>\n

Both companies are gearing up to meet the expected demand for these pioneering medications, emphasizing their commitment to providing effective treatments to those in need. Yet, amidst the rush for commercial success, there\u2019s a call for reflection on how we manage our health\u2014a responsibility that intertwines physical, emotional, and spiritual well-being.<\/p>\n

An Encouraging Takeaway<\/strong><\/p>\n

As we witness this competition unfold, consider how these developments reflect our own journey towards wholeness. The pursuit of better health, whether through medications or lifestyle changes, can be understood as not just a quest for physical well-being but also a spiritual one. Embracing healthy choices is a way to honor our bodies as gifts from God.<\/p>\n

In this light, let us engage with our health journey thoughtfully and intentionally, remembering that every step taken in pursuit of wellness is a step towards fulfilling our purpose. May we find encouragement not only in advances in medicine but in the richness of a life well-lived\u2014body, mind, and spirit.<\/p>\n

\n

Source link <\/a><\/p>\n

\n

Explore and dig up answers yourself with our BGodInspired App<\/a>. Be careful \u2013 each interaction is like a new treasure hunt\u2026 you can get lost for hours \ud83d\ude42<\/p>\n

\n
\n \n
\n \n \"Happy\"\n <\/a>\n
\n Happy <\/div>\n
\n 0<\/span>\n \n 0<\/span> %<\/span>\n <\/div>\n <\/div>\n\n
\n \n \"Sad\"\n <\/a>\n
\n Sad <\/div>\n
\n 0<\/span>\n 0<\/span> %<\/span>\n <\/div>\n <\/div>\n\n
\n \n \"Excited\"\n <\/a>\n
\n Excited <\/div>\n
\n 0<\/span>\n 0<\/span> %<\/span>\n <\/div>\n <\/div>\n\n
\n \n \"Sleepy\"\n <\/a>\n
\n Sleepy <\/div>\n
\n 0<\/span>\n \n 0<\/span> %<\/span>\n <\/div>\n <\/div>\n\n
\n \n \"Angry\"\n <\/a>\n
Angry<\/div>\n
\n 0<\/span>\n 0<\/span> %<\/span>\n \n <\/div>\n <\/div>\n\n
\n \n \"Surprise\"\n <\/a>\n
Surprise<\/div>\n
\n 0<\/span>\n 0<\/span> %<\/span>\n <\/div>\n <\/div>\n\n <\/div>\n <\/div>\n\n ","protected":false},"excerpt":{"rendered":"

The Race for Weight-Loss Supremacy: Eli Lilly vs. Novo Nordisk In a rapidly evolving weight-loss market, pharmaceutical giants Eli Lilly and Novo Nordisk are racing to bring obesity pills to the forefront. Both companies, having successfully launched their injectable weight-loss medications, are making significant strides towards oral alternatives that could transform treatment for millions battling […]<\/p>\n","protected":false},"author":1,"featured_media":72056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5224],"tags":[3591],"class_list":["post-72055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bgodinspired-health-news","tag-bgodinspired-news"],"_links":{"self":[{"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/posts\/72055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/comments?post=72055"}],"version-history":[{"count":0,"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/posts\/72055\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/media\/72056"}],"wp:attachment":[{"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/media?parent=72055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/categories?post=72055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bgodinspired.com\/index.php\/wp-json\/wp\/v2\/tags?post=72055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}